Neoadjuvant chemotherapy should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer of the bladder (MIBC): A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process

Neoadjuvant chemotherapy (NC) improves overall survival in patients with resectable muscle-invasive urothelial cancer of the bladder (MIBC). However uptake of NC in Canada is dis-appointingly low. Following a detailed literature review and in consultation with urologic oncology, the Canadian Associa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Seah, Jo-An, Blais, Normand, North, Scott, Rahim, Yasmin, Ruether, Dean, Black, Peter C., Zlotta, Alexandre R., Wood, Lori, Sridhar, Srikala S.
Format: Artigo
Idioma:Inglês
Publicat: Canadian Medical Association 2013
Matèries:
Consensus Statement
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3854467/
https://ncbi.nlm.nih.gov/pubmed/24319508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.1506
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars